George Maybach - Author for 24/7 Wall St.
Lastest Stories by George Maybach
Jefferies has upgraded its outlook for Acushnet to Buy.
Published:
Goldman Sachs maintained coverage of Applied Materials with a Buy recommendation.
Published:
J.P. Morgan has downgraded its outlook for Medical Properties Trust to Underweight.
Published:
Goldman Sachs has maintained coverage of Walmart with a Buy recommendation.
Published:
Orbimed Advisors has disclosed a 5.9% stake in Galecto.
Published:
Morningside Venture Investments has disclosed a 6.86% stake in Amylyx Pharmaceuticals.
Published:
Cannell Capital has disclosed a 8.45% stake in Neuronetics.
Published:
Edward Jones has downgraded its outlook for CVS Health to Hold.
Published:
Rosenblatt has upgraded its outlook for Lumentum to Buy.
Published:
J.P. Morgan has downgraded its outlook for Farfetch to Neutral.
Published:
Goldman Sachs has maintained coverage of H&R Block with a Sell recommendation.
Published:
Wells Fargo has upgraded its outlook for Hawaiian Electric Industries to Equal Weight.
Published:
Citigroup has upgraded its outlook for CRISPR Therapeutics to Buy.
Published:
BTIG has downgraded its outlook for Invitation Homes to Neutral.
Published:
Goldman Sachs maintained coverage of DLocal with a Buy recommendation.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.